Skip to main content
Back
Watch Compare

60 DEGREES PHARMACEUTICALS, INC.

Data quality: 100%
Also listed as SXTPW Nasdaq
SXTP
Nasdaq Manufacturing Chemicals
$1.76
▲ $0.02 (1.15%)
Mkt Cap: 4.59 M
Price
$1.74
Mkt Cap
4.59 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Debt/Equity of 0.03 — conservative balance sheet
Negative free cash flow of -6.99 M

Growth

Revenue Growth (5Y)
N/A
Revenue (1Y)65.49%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-214.78%
Below sector avg (-53.34%)
ROIC-175.55%
Net Margin-732.51%
Op. Margin-771.64%

Safety

Debt / Equity
0.03
Below sector avg (0.31)
Current Ratio2.87
Interest Coverage-994.05

Valuation

PE (TTM)
-0.62
Above sector avg (-1.47)
P/B Ratio1.04
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (1364 peers)
Metric Stock Sector Median
P/E -0.6 -1.5
P/B 1.0 1.6
ROE % -214.8 -53.3
Net Margin % -732.5 -41.5
Rev Growth 5Y % — 1.8
D/E 0.0 0.3

Analyst Price Target

2 analysts
Buy
Current
$1.76
+900.0%
Target
$17.60
$11.20
$17.60
$24.00
Forecast
Forward EPS -$2.16
Est. Revenue 2.80 M

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 -$2.16
-$2.16 – -$2.16
 2.80 M 1
FY2026 -$7.88
-$7.88 – -$7.88
 2.00 M 1

Earnings Surprises

Last 4 quarters
Quarter Est. EPS Actual EPS Surprise
Q42025 -$2.00 -$8.17 -308.6%
Q32025 -$1.84 -$2.53 -37.6%
Q22025 -$4.96 -$4.33 +12.8%
Q12025 -$5.28 -$5.96 -12.9%

All Fundamental Metrics
Growth
Revenue Growth (1Y) 65.49% Revenue Growth (3Y) 99.13%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1.01 M Net Income (TTM) -7.37 M
ROE -214.78% ROA -135.50%
Gross Margin 22.26% Operating Margin -771.64%
Net Margin -732.51% Free Cash Flow (TTM) -6.99 M
ROIC -175.55% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.03 Current Ratio 2.87
Interest Coverage -994.05 Asset Turnover 0.19
Working Capital 4.11 M Tangible Book Value 4.28 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0.62 Forward P/E N/A
P/B Ratio 1.04 P/S Ratio 4.56
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -152.33%
Market Cap 4.59 M Enterprise Value 622,234.0
Per Share
EPS (Diluted TTM) -11.73 Revenue / Share 0.38
FCF / Share -2.65 OCF / Share -2.60
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 13.91% FCF Conversion 94.89%
SBC-Adj. FCF -6.92 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023
Revenue 1.01 M 607,574.0 253,573.0
Net Income -7.37 M -7.95 M -3.77 M
EPS (Diluted) -11.73 -18.55 -0.99
Gross Profit 223,776.0 222,809.0 -220,977.0
Operating Income -7.76 M -9.71 M -5.15 M
EBITDA — — —
R&D Expenses 2.11 M 4.99 M 691,770.0
SG&A Expenses — — —
D&A 43,324.0 11,726.0 —
Interest Expense 7,805.0 0.0 2.29 M
Income Tax 0.0 250.0 250.0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023
Total Assets 5.37 M 5.76 M 7.78 M
Total Liabilities 1.99 M 1.80 M 2.99 M
Shareholders' Equity 3.46 M 4.04 M 4.87 M
Total Debt 150,000.0 200,000.0 150,000.0
Cash & Equivalents 1.51 M 1.66 M —
Current Assets 4.90 M 5.39 M 7.24 M
Current Liabilities 1.84 M 1.66 M 2.84 M